These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21642633)

  • 1. Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program.
    Willett CE; Bishop PL; Sullivan KM
    Toxicol Sci; 2011 Sep; 123(1):15-25. PubMed ID: 21642633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results.
    Borgert CJ; Mihaich EM; Quill TF; Marty MS; Levine SL; Becker RA
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):397-411. PubMed ID: 21251942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
    Bishop PL; Willett CE
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program.
    Juberg DR; Borghoff SJ; Becker RA; Casey W; Hartung T; Holsapple MP; Marty MS; Mihaich EM; Van Der Kraak G; Wade MG; Willett CE; Andersen ME; Borgert CJ; Coady KK; Dourson ML; Fowle JR; Gray LE; Lamb JC; Ortego LS; Schug TT; Toole CM; Zorrilla LM; Kroner OL; Patterson J; Rinckel LA; Jones BR
    ALTEX; 2014; 31(1):63-78. PubMed ID: 24114257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations".
    Marty S
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program.
    Borgert CJ; Mihaich EM; Ortego LS; Bentley KS; Holmes CM; Levine SL; Becker RA
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):185-91. PubMed ID: 21803110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic benefits of using adaptive predictive models of reproductive toxicity in the context of a tiered testing program.
    Martin MT; Knudsen TB; Judson RS; Kavlock RJ; Dix DJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):3-9. PubMed ID: 22239076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
    Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
    J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorpyrifos: weight of evidence evaluation of potential interaction with the estrogen, androgen, or thyroid pathways.
    Juberg DR; Gehen SC; Coady KK; LeBaron MJ; Kramer VJ; Lu H; Marty MS
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):249-63. PubMed ID: 23524272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals.
    Firestone M; Kavlock R; Zenick H; Kramer M;
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):139-62. PubMed ID: 20574895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.
    Browne P; Noyes PD; Casey WM; Dix DJ
    Environ Health Perspect; 2017 Sep; 125(9):096001. PubMed ID: 28934726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ammonium perchlorate in the endocrine disruptor screening and testing program's male pubertal protocol: ability to detect effects on thyroid endpoints.
    Stoker TE; Ferrell JM; Laws SC; Cooper RL; Buckalew A
    Toxicology; 2006 Nov; 228(1):58-65. PubMed ID: 17011691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainties for endocrine disrupters: our view on progress.
    Daston GP; Cook JC; Kavlock RJ
    Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB
    Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
    O'Connor JC; Cook JC; Marty MS; Davis LG; Kaplan AM; Carney EW
    Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis-driven weight of evidence evaluation indicates styrene lacks endocrine disruption potential.
    Borgert CJ
    Crit Rev Toxicol; 2023 Feb; 53(2):53-68. PubMed ID: 37216681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.
    Stump DG; O'Connor JC; Lewis JM; Marty MS
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):43-62. PubMed ID: 24510766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study.
    Paul Friedman K; Papineni S; Marty MS; Yi KD; Goetz AK; Rasoulpour RJ; Kwiatkowski P; Wolf DC; Blacker AM; Peffer RC
    Crit Rev Toxicol; 2016 Oct; 46(9):785-833. PubMed ID: 27347635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.